About Christopher Lehman
Form D filings for Eureka Therapeutics in 2018 list Christopher Lehman as executive officer.
Christopher Lehman first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Lehman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Lehman works with at each company, as listed on that company's latest Form D.
Eureka Therapeutics, Inc. · Form D, Jun 18, 2018
BF
Bo Feng
Director
LW
Lewis Williams
Director
CC
Chih-Kai "C.K." Cheng
Director
MC
Michael Cannon
Director
BN
Bijan Nejadnik
Executive officer
WI
William Solari III
Director
VS
Victor Shum
General Counsel
WC
Wai-Yan "Sandy" Chau
Director
CL
Cheng Liu
Executive officer and director